Real-world assessment of effectiveness and safety profile of remogliflozin etabonate in management of type 2 diabetes mellitus

被引：0
|
作者：
Bipin Sethi
Subhankar Chowdhury
Supratik Bhattacharya
Sagar Katare
Sachin Suryawanshi
Hanmant Barkate
机构：
[1] Care Hospital,Department of Endocrinology
[2] IPGME&R and SSKM Hospital,Department of Endocrinology
[3] SKN Diabetes Center,Department of Endocrinology
[4] Glenmark Pharmaceuticals Limited,Global Medical Affairs
来源：
International Journal of Diabetes in Developing Countries | 2023年 / 43卷
关键词：
Remogliflozin etabonate; Type 2 diabetes mellitus; HbA1c; Adverse events;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：214 / 225
页数：11
相关论文
共 50 条
  • [1] Real-world assessment of effectiveness and safety profile of remogliflozin etabonate in management of type 2 diabetes mellitus
    Sethi, Bipin
    Chowdhury, Subhankar
    Bhattacharya, Supratik
    Katare, Sagar
    Suryawanshi, Sachin
    Barkate, Hanmant
    [J]. INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2023, 43 (02) : 214 - 225
  • [2] Real world assessment of effectiveness and safety of FDC of remogliflozin etabonate and Vildagliptin in T2DM patients
    Bhattacharyya, S.
    Katare, S.
    Khaladkar, K.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [3] A real-world clinical experience on effectiveness of remogliflozin etabonate in management of Indian patients with T2DM
    Mahapatra, H.
    Dalai, S.
    Sahoo, A.
    Khuntia, M.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [4] Efficacy and Safety of Twice Daily Remogliflozin Etabonate for the Treatment of Type 2 Diabetes
    Sykes, Andy
    Wilkison, William O.
    Kler, Lata
    Lorimer, Jamie
    Dorey, David
    Dobbins, Robert L.
    O'Connor-Semmes, Robin
    [J]. DIABETES, 2014, 63 : A287 - A287
  • [5] Efficacy and Safety of Once Daily Remogliflozin Etabonate for the Treatment of Type 2 Diabetes
    Sykes, Andy
    Wilkison, William O.
    Kler, Lata
    Kemp, Gail
    Almond, Steve
    Dobbins, Robert L.
    O'Connor-Semmes, Robin
    [J]. DIABETES, 2014, 63 : A287 - A287
  • [6] A Real-World Overview of Diabetes Mellitus Profile and Management in Brazil
    Chacra, Antonio R.
    Franco, Denise R.
    Calliari, Luis E. P.
    Eliaschewitz, Freddy G.
    Ferreira, Graziela
    Paula, Mauricio A.
    Lima, Leila
    Lauand, Felipe
    [J]. DIABETES, 2017, 66 : A653 - A653
  • [7] Real-World Effectiveness of Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Literature Review
    Robinson, Susan
    Boye, Kristina S.
    Mody, Reema
    Strizek, Alena Antonie
    Konig, Manige
    Malik, Raleigh E.
    Kennedy-Martin, Tessa
    [J]. DIABETES THERAPY, 2020, 11 (07) : 1437 - 1466
  • [8] Real-World Effectiveness of Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Literature Review
    Susan Robinson
    Kristina S. Boye
    Reema Mody
    Alena Antonie Strizek
    Manige Konig
    Raleigh E. Malik
    Tessa Kennedy-Martin
    [J]. Diabetes Therapy, 2020, 11 : 1437 - 1466
  • [9] Efficacy and Safety of IDegAsp in a Real-World Korean Population with Type 2 Diabetes Mellitus
    Kang, Shinae
    Ahn, Yu-Bae
    Oh, Tae Keun
    Lee, Won-Young
    Chun, Sung Wan
    Bae, Boram
    Dahaoui, Amine
    Jeong, Jin Sook
    Jung, Sungeun
    Jang, Hak Chul
    [J]. DIABETES & METABOLISM JOURNAL, 2024, 48 (05)
  • [10] Safety and Effectiveness of Dulaglutide in the Treatment of Type 2 Diabetes Mellitus : A Korean Real-World Post-Marketing Study
    Han, Jeonghee
    Lee, Woo Je
    Hur, Kyu Yeon
    Cho, Jae Hyoung
    Lee, Byung Wan
    Park, Cheol-Young
    [J]. DIABETES & METABOLISM JOURNAL, 2024, 48 (03)
12345